Jean-Baptiste Woillard
  • Since 2014: Associate Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
  • 2010-2014: Assistant Professor in the Pharmacology, Toxicology Department, University Hospital of Limoges/ INSERM U1248, University of Limoges, Limoges (France)
  • 2008-2011: PhD at the INSERM U850, University of Limoges, Limoges (France)
  • 2004-2008: Pharmacy residency at the University Hospital of Limoges, Limoges (France)
  • 1998-2004: PharmD at the University of Toulouse (Faculty of Pharmacy), Toulouse (France)
  • 2019 Accreditation to supervise research (HDR – French postdoctoral degree)
  • 2011 PhD degree, Université Limoges, France
  • 2008 PharmD degree, Faculty of Pharmacy, Toulouse, France
  • 2007 Master degree, Université Paris V, Paris, France

Research interest:

  • Pharmacogenetics
  • Pharmacometrics
  • Application of machine learning to drug individualisation

Awards:

  • IFCC-Gérard Siest Award (Young Scientist Award for Distinguished Contributions in Pharmacogenetics) 2020
  • Award of the French Society of Pharmacology and Therapeutics, 2015 and 2017

Invited conference and oral communications:

  • 26 oral communications (12 in France and 14 abroad)
  • 9 invited conferences Academic and Industry (5 in France and 4 abroad)

Positions in learned societies:

  • Member of the ISOP-ACCP Clinical Pharmacometrics Special Interest Group Steering Committee (Chair Dr. M. Neely) 2017-2020
  • Co-chair of Pharmacometrics committee of IATDMCT since 2018

Membership in learned societies:

  • Member of International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT)
  • Member of European Association for Clinical Pharmacology and Therapeutics (EACPT)
  • Member of Société Française de Pharmacologie et Thérapeutique (SFPT)
  • Member of groupe Suivi Thérapeutique Pharmacologique (groupe STP) of SFPT
  • Member of Réseau National de Pharmacogénétique (RNPGx)

Consensus conferences:

  • Participated in 2 international consensus conferences about immunosuppressive drugs (Tacrolimus and MMF)

Number of publications:

  • 78 peer-reviewed manuscripts